B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HTR1E

MOLECULAR TARGET

5-hydroxytryptamine receptor 1E

UniProt: P28566NCBI Gene: 335420 compounds

HTR1E (5-hydroxytryptamine receptor 1E) is targeted by 20 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HTR1E

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Sumatriptan2.4811
2Methysergide2.4010
3Metergoline2.208
4Ergotamine1.614
5Methylergonovine1.614
6Quetiapine Fumarate1.102
7brl 155721.102
8Dihydroergotamine1.102
9Dihydroergotamine1.102
10Ergonovine1.102
11Fluspirilene1.102
12Lysergic Acid Diethylamide Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is1.102
13Yohimbine1.102
14Lisuride0.691
15Mescaline Hallucinogenic alkaloid isolated from0.691
16Phentolamine0.691
17Pindolol0.691
18Podophyllotoxin0.691
19triflupromazine hydrochloride0.691
20vinblastine sulfate0.691

About HTR1E as a Drug Target

HTR1E (5-hydroxytryptamine receptor 1E) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 20 compounds with documented HTR1E interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HTR1E inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.